Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Inverse relationship between cagG-positive Helicobacter pylori status and risk of gastric ulcer.

Bakhti SZ, Raei N, Latifi-Navid S, Zahri S, Yazdanbod A.

Br J Biomed Sci. 2019 Jan 8:1-3. doi: 10.1080/09674845.2018.1564418. [Epub ahead of print] No abstract available.

PMID:
30616430
2.

Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports.

Latifi-Navid H, Latifi-Navid S, Mostafaiy B, Jamalkandi SA, Ahmadi A.

Sci Rep. 2018 Jul 23;8(1):11051. doi: 10.1038/s41598-018-29280-2.

3.

Enhanced anti-bacterial activities of ZnO nanoparticles and ZnO/CuO nanocomposites synthesized using Vaccinium arctostaphylos L. fruit extract.

Mohammadi-Aloucheh R, Habibi-Yangjeh A, Bayrami A, Latifi-Navid S, Asadi A.

Artif Cells Nanomed Biotechnol. 2018 Mar 11:1-10. doi: 10.1080/21691401.2018.1448988. [Epub ahead of print]

PMID:
29527924
4.

Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran.

Bakhti SZ, Latifi-Navid S, Zahri S, Bakhti FS, Hajavi N, Yazdanbod A.

Cancer Biomark. 2017 Dec 12;21(1):235-246. doi: 10.3233/CBM-170701.

PMID:
29036792
5.

Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran.

Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Safaralizadeh R.

Microb Pathog. 2017 Jun;107:287-292. doi: 10.1016/j.micpath.2017.04.007. Epub 2017 Apr 5.

PMID:
28390977
6.

Role of Plasticity Region Genes and cagE gene of cagPAI of Helicobacter pylori in Development of Gastrointestinal (GI) Diseases

GholizadeTobnagh Sh, Bakhti SZ, Latifi Navid S, Zahri S, Sadat Bakhti F.

Asian Pac J Cancer Prev. 2017 Jan 1;18(1):43-49.

7.

Helicobacter pylori virulence factors in relation to gastrointestinal diseases in Iran.

Safaralizadeh R, Dastmalchi N, Hosseinpourfeizi M, Latifi-Navid S.

Microb Pathog. 2017 Apr;105:211-217. doi: 10.1016/j.micpath.2017.02.026. Epub 2017 Feb 20. Review.

PMID:
28232251
8.

Helicobacter pylori Infection and Dietary Factors Act Synergistically to Promote Gastric Cancer.

Raei N, Behrouz B, Zahri S, Latifi-Navid S.

Asian Pac J Cancer Prev. 2016;17(3):917-21. Review.

9.

Helicobacter pylori babA2 Positivity Predicts Risk of Gastric Cancer in Ardabil, a Very High-Risk Area in Iran.

Abdi E, Latifi-Navid S, Yazdanbod A, Zahri S.

Asian Pac J Cancer Prev. 2016;17(2):733-8.

10.

Helicobacter pylori vacuolating cytotoxin genotypes and preneoplastic lesions or gastric cancer risk: a meta-analysis.

Abdi E, Latifi-Navid S, Latifi-Navid H, Safarnejad B.

J Gastroenterol Hepatol. 2016 Apr;31(4):734-44. doi: 10.1111/jgh.13256.

PMID:
26648346
11.

Relevance of Helicobacter pylori vacA 3'-end Region Polymorphism to Gastric Cancer.

Bakhti SZ, Latifi-Navid S, Mohammadi S, Zahri S, Bakhti FS, Feizi F, Yazdanbod A, Siavoshi F.

Helicobacter. 2016 Aug;21(4):305-16. doi: 10.1111/hel.12284. Epub 2015 Nov 27.

PMID:
26612250
12.
13.

Multiple repeats of Helicobacter pylori CagA EPIYA-C phosphorylation sites predict risk of gastric ulcer in Iran.

Honarmand-Jahromy S, Siavoshi F, Malekzadeh R, Sattari TN, Latifi-Navid S.

Microb Pathog. 2015 Dec;89:87-92. doi: 10.1016/j.micpath.2015.09.005. Epub 2015 Sep 25.

PMID:
26408373
14.

Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Honarmand-Jahromy S, Siavoshi F, Malekzadeh R, Nejad Sattari T, Latifi-Navid S.

World J Gastroenterol. 2015 Aug 21;21(31):9317-27. doi: 10.3748/wjg.v21.i31.9317.

15.

Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran.

Mottaghi B, Safaralizadeh R, Bonyadi M, Latifi-Navid S, Somi MH.

Clin Exp Med. 2016 Feb;16(1):57-63. doi: 10.1007/s10238-014-0327-0. Epub 2014 Dec 4.

PMID:
25472424
16.

Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in northwestern Iran.

Basiri Z, Safaralizadeh R, Bonyadi MJ, Somi MH, Mahdavi M, Latifi-Navid S.

Asian Pac J Cancer Prev. 2014;15(4):1575-9.

17.

Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran.

Latifi-Navid S, Mohammadi S, Maleki P, Zahri S, Yazdanbod A, Siavoshi F, Massarrat S.

Arch Iran Med. 2013 Jun;16(6):330-7. doi: 013166/AIM.005.

18.

Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastric cancer patients.

Siavoshi F, Asgharzadeh A, Ghadiri H, Massarrat S, Latifi-Navid S, Zamani M.

Int J Med Microbiol. 2011 Aug;301(6):506-12. doi: 10.1016/j.ijmm.2011.03.002. Epub 2011 Jun 8.

PMID:
21641279
19.

The role and frequency of glutathione s-transferase P1 polymorphism in Iranian patients affected with reflux esophagitis.

Zendehdel N, Biramijamal F, Zendehdel N, Sarie H, Doughaiemoghaddam M, Pourshams A, Latifi-Navid S, Dehghani M.

Dis Esophagus. 2010 Sep;23(7):603-7. doi: 10.1111/j.1442-2050.2010.01063.x. Epub 2010 May 4.

PMID:
20459448
20.

Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.

Siavoshi F, Saniee P, Latifi-Navid S, Massarrat S, Sheykholeslami A.

Arch Iran Med. 2010 May;13(3):177-87.

Supplemental Content

Loading ...
Support Center